Loading…
Loading…
EQUITY / NASDAQ · XNCM
Work Medical Technology Group Ltd. Class A Ordinary Shares
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →10/01/2024 – 09/30/2025 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗1.6 USD · 9.215%
Observed: Oct 5, 2026, 11:49 PM · TickerLayer indicative price; may be delayed
Powered by TickerLayer
10/05/2026 · 1.465 USD · Volume 149,577
20 actual observations · Latest bar: 2026-10-05 · Market data is indicative; provider terms apply.
3 available financial reports
Research reports →SEC FINANCIAL REPORTS
10/01/2024 – 09/30/2025 · Units
| Metric | 2025 / Year end | 2024 / Year end | Change |
|---|---|---|---|
| Net income | -1,072,667 USD | -3,492,318 USD | — |
| Operating cash flow | 6,244,285 USD | -2,228,087 USD | — |
| Cash and cash equivalents | 4,088,599 USD | 6,557,605 USD | -37.65% |
| Total liabilities | 11,991,525 USD | 20,180,190 USD | -40.58% |
| Total equity | 18,338,941 USD | 13,185,926 USD | +39.08% |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2025 / Year end10/01/2024 – 09/30/2025ConsolidatedUnits · USD | 2024 / Year end10/01/2023 – 09/30/2024ConsolidatedUnits · USD | 2023 / Year end10/01/2022 – 09/30/2023ConsolidatedUnits · USD |
|---|---|---|---|
| Capital expendituresCash flow statement | 1,332,507 USD | 9,225,094 USD | 455,391 USD |
| Cash and cash equivalentsBalance sheet | 4,088,599 USD | 6,557,605 USD | 1,596,096 USD |
| Financing cash flowCash flow statement | -898,212 USD | 15,657,024 USD | -728,719 USD |
| Gross profitIncome statement | 2,344,854 USD | 2,868,386 USD | 4,142,984 USD |
| Investing cash flowCash flow statement | -7,607,719 USD | -9,064,079 USD | -583,304 USD |
| Net incomeIncome statement | -1,072,667 USD | -3,492,318 USD | 112,030 USD |
| Operating cash flowCash flow statement | 6,244,285 USD | -2,228,087 USD | 2,209,736 USD |
| Total assetsBalance sheet | 33,156,256 USD | 36,250,563 USD | — |
| Total equityBalance sheet | 18,338,941 USD | 13,185,926 USD | 10,985,915 USD |
| Total liabilitiesBalance sheet | 11,991,525 USD | 20,180,190 USD | — |
| Report source | Open report ↗ Published: 01/30/2026 | Open report ↗ Published: 01/30/2026 | Open report ↗ Published: 01/30/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.